Takeda taps Lilly exec to run U.S. unit, adding a woman to its all-male exec team

Takeda has chosen a woman to run its U.S. pharma business, just weeks after new CEO Christophe Weber said he was unhappy with the gender balance in the Japanese drugmaker's management ranks. Weber recruited Eli Lilly ($LLY) USA exec Ramona Sequeira to replace Doug Cole, who announced his departure last November. More from FiercePharmaAsia | Release

Suggested Articles

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

Just a few months after playing a pivotal role in Sanofi’s Bioverativ buy, Alex Denner has set his sights on Ironwood.

Clovis' new approval will boost Rubraca in recurrent ovarian cancer, but because of its competitors' head start, the race will be tough.